Align Technology (ALGN) Expected to Announce Quarterly Earnings on Wednesday

Align Technology (NASDAQ:ALGN) is expected to announce its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $2.99 per share and revenue of $1.0318 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 4, 2026 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.23. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.The firm had revenue of $995.69 million during the quarter, compared to analysts’ expectations of $980.75 million. During the same quarter last year, the firm earned $2.35 earnings per share. The business’s revenue for the quarter was up 1.8% on a year-over-year basis. On average, analysts expect Align Technology to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $167.04 on Wednesday. Align Technology has a one year low of $122.00 and a one year high of $232.20. The business’s 50-day moving average price is $159.35 and its two-hundred day moving average price is $149.57. The company has a market capitalization of $11.99 billion, a P/E ratio of 32.37, a price-to-earnings-growth ratio of 1.88 and a beta of 1.83.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on ALGN shares. Weiss Ratings upgraded Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, January 16th. HSBC increased their price target on shares of Align Technology from $140.00 to $150.00 in a research note on Friday, October 31st. Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a research note on Thursday, October 30th. UBS Group lowered their target price on shares of Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a research report on Thursday, October 16th. Finally, Wall Street Zen upgraded Align Technology from a “hold” rating to a “buy” rating in a report on Saturday, January 3rd. Six investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $176.82.

Hedge Funds Weigh In On Align Technology

A number of institutional investors have recently made changes to their positions in ALGN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Align Technology by 4.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,222 shares of the medical equipment provider’s stock valued at $1,624,000 after buying an additional 469 shares during the last quarter. Focus Partners Wealth boosted its position in shares of Align Technology by 5.2% in the first quarter. Focus Partners Wealth now owns 3,062 shares of the medical equipment provider’s stock valued at $486,000 after acquiring an additional 151 shares during the period. Sivia Capital Partners LLC acquired a new stake in shares of Align Technology in the second quarter worth $204,000. EverSource Wealth Advisors LLC increased its position in Align Technology by 55.7% during the second quarter. EverSource Wealth Advisors LLC now owns 531 shares of the medical equipment provider’s stock worth $101,000 after acquiring an additional 190 shares during the period. Finally, First Trust Advisors LP raised its stake in Align Technology by 201.7% during the 2nd quarter. First Trust Advisors LP now owns 88,270 shares of the medical equipment provider’s stock valued at $16,712,000 after purchasing an additional 59,010 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.